Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?

Up to 18% of patients with acute myeloid leukemia (AML) present with a white blood cell (WBC) count of greater than 100,000/µL, a condition that is frequently referred to as hyperleukocytosis. Hyperleukocytosis has been associated with an adverse prognosis and a higher incidence of life-threatening...

Descripción completa

Detalles Bibliográficos
Autores principales: Bewersdorf, Jan Philipp, Zeidan, Amer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603052/
https://www.ncbi.nlm.nih.gov/pubmed/33080779
http://dx.doi.org/10.3390/cells9102310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603052/
https://www.ncbi.nlm.nih.gov/pubmed/33080779
http://dx.doi.org/10.3390/cells9102310

Ejemplares similares